Joint Hypermobility SyndromeNCT05633225
Central Sensitization and Physical Activity in Adolescents With HSD/hEDS
An observational study of Joint Hypermobility Syndrome and Hypermobile Ehlers-Danlos Syndrome, run by Vastra Gotaland Region at 2 sites in Sweden.
Trial summary
Hypermobility Spectrum Disorder and hypermobile Ehlers-Danlos Syndrome (HSD/hEDS) is under-recognized and poorly understood and its management is therefore not clear. The goal of this study is to better understand pain and its impact on function in the daily activities of adolescents with Hypermobility Spectrum… Read more about this study
- Who is it for?
- Ages 13 to 17 yearsHealthy volunteers can take part
- Conditions the study is for
- Joint Hypermobility Syndrome, Hypermobile Ehlers-Danlos Syndrome
- What is being tested?
- Submax exercise test on a bicycle ergometer
- How many people
- 100 participants
- Where
- 2 sitesSweden
- Study dates
- 25 Nov 2022to 31 Oct 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 to 17 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: Adolecents diagnosed with HSD/hEDS, at Children's Primary Health Care Clinics in Gothenburg and Southern Bohuslän, and at Queen Silvia Children's Hospital and Skaraborgs hospital Skövde will be asked to participate. In addition, a control group of healthy pain free adolecents, matched for sex, age will be recruited from different schools in the region, throw hospital stuff and social media.
Who may be able to join
- Able to read and understand Swedish
- Diagnosed with HSD or hEDS
- Able to read and understand Swedish
- Healthy
- Pain free at time of investigation (Numerical Rating Scale score <3/10).
Who cannot join
- Pregnancy and one year postpartum.
- Other syndromes with hypermobility such as the Marfan syndrome, Osteogenesis Imperfecta or other types of EDS.
- Co-morbidity with neurological disorders
- Pregnancy and one year postpartum.
- Past or present signs of rheumatic, neurologic, musculoskeletal, metabolic diseases.
- Chronic pain.
Trial locations and contacts
2 sites in 1 country.
Sweden2 sites
Sahlgrenska University Hospital
Gothenburg, Region Västra Götaland, 416 85
Skaraborgs Hospital Skövde
Skövde, Region Västra Götaland, 54142
About this study
Official title: Measuring Central Sensitization and Physical Activity in Adolescents With Hypermobility Spectrum Disorder or Hypermobile Ehlers-Danlos Syndrome
Hypermobility Spectrum Disorder and hypermobile Ehlers-Danlos Syndrome (HSD/hEDS) is under-recognized and poorly understood and its management is therefore not clear.
The goal of this study is to better understand pain and its impact on function in the daily activities of adolescents with Hypermobility Spectrum Disorder and/or hypermobile Ehlers-Danlos Syndrome.
This study will explore the presence of the pain sensitivity status after physical exercise as well as movement behaviour in adolescents with HSD/hEDS compared to a healthy control group.
Read the detailed description
All participants will be asked not to undertake physical exercise at least 48 hours before the measurements, and to refrain from consuming caffeine, alcohol or nicotine. For ethical reasons, the patients are allowed to take non-opioid pain medicine as described in the first step of the World Health Organization analgesic ladder (COX-inhibitors and paracetamol), however the patients will be asked to abstain from these medications during the 24 hours period before the measurements.
- Being tested
- Submax exercise test on a bicycle ergometer
- Keywords
- Pain, Hypermobility, Physical activity, Central sensitization, Fatigue, Ehlers Danlos Syndrome
- Medical subject headings
- Ehlers-Danlos syndrome type 3, Pain, Motor Activity, Fatigue, Ehlers-Danlos Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Submax exercise test on a bicycle ergometerOther
To achieve exertion and not exhaustion, cycling will be stopped at 75% of the expected maximum heart rate (maximum heart rate of 220 beats per minute minus age) as a target value.
If the participant then indicated that they do not feel strained, the cycling will continue until the participant experienced an effort on Borg Rating of Perceived Exertion Scale scale of 15 (hard).
| Study group | Role | What they receive |
|---|---|---|
| Patient-group | Ninety adolescents, 13-17 years of age Diagnosed with Hypermobility Spectrum Disorder or hypermobile Ehlers Danlos Syndrome. Receives: Other: Submax exercise test on a bicycle ergometer | |
| Control-group | Ninety adolescents, 13-17 years of age. Participants have to be pain free at time of investigation (NRS score <3/10) Receives: Other: Submax exercise test on a bicycle ergometer |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pressure Pain thresholds, primary and secondary hyperalgesia
A hand-held pressure algometer (Wagner Instruments, FPX 25) will be used to assess pressure pain thresholds (PPT).
The 1 cm2 rubber tip of the algometer will be positioned at an angle of 90 degrees in relation to the body part evaluated and pressure will be applied at a rate of 1 kg/s.
PPT measurements will be carried out on the lower back in the supine position, on the tibialis anterior in the prone position, on the trapezius and deltoid while sitting.
The participants will be instructed to say "stop" as soon as the sensation of a pressure changes to an uncomfortable feeling. The pressure algometer will be removed immediately and the recorded value will be noted.
This procedure will be repeated time three times at each test location (30 seconds between each measurement). Average value of the last two measurements is used as the baseline.
The order of the PPT measurement points will be randomized for each group.
Measured: Baseline, pre-intervention
Change of Pressure Pain thresholds, exercise-induced hyperalgesia
Exercise-induced hyperalgesia will be measured by repeating the pressure pain thresholds (PPT) measures at the trapezius muscle and the tibialis anterior muscle (as described above) immediately after the performance of an submax exercise test on a bicycle ergometer
The order of the PPT measurement points in the exercise-induced hyperalgesia measurements will be randomized for each group.
Measured: Immediately after the intervention
Secondary outcomes (14)
Numerical rating scale
Average pain intensity will be measured using a 0-10 numerical rating scale (NRS) , with 0 = "no pain" and 10 = "worst possible pain" as the endpoint.
Measured: Baseline, pre-intervention and immediately after the intervention
Heart rate
Peak heart rate immediately after a cycling test (heartbeat/min) will be recorded.
Measured: Immediately after the intervention
Borg Rating of Perceived Exertion Scale
The subjective perceived effort of physical activity is measured with Borg Rating of Perceived Exertion Scale (Borg's RPE scale).
Borg´s RPE measures physical activity intensity. Perceived exertion of how hard the individual feels the body is working. The individual experienced physical sensations during physical activity (increased heart rate, increased breathing or breathing rate, increased sweating and muscle fatigue)
The scale goes from 6 "No effort at all" to 20 "Maximum effort" .
Measured: Immediately after the intervention
Medical examination
Medical examination according to the 2017 criteria for Hypermobility Spectrum Disorder or HSD/hEDS (hEDS Diagnostic Checklist).
Include assessment of joint mobility according to the Beighton scale (described below), physical examination of the diagnostic criteria for hEDS, family history of hEDS, and presence of musculoskeletal pain and joint dislocations.
Measured: Baseline, pre-intervention
Beighton scale
The Beighton scale assesses 9 joints for hypermobility. Hyperextension in elbow joint bilaterally >10 degrees, hyperextension in knee joint bilaterally > 10 degrees, hyperextension of the fifth finger bilaterally > 90 degrees, ability to move the thumb towards the forearm bilaterally and trunk flexion in standing (palm completely on the surface).
A total of 9 points is possible, generally hypermobility is achieved at 6 points for children and adolescence.
Measured: Baseline, pre-intervention
Demographics child
Back ground data like age, sex ,onset, diagnosis, date of diagnosis, HSD/hED, family history of hypermobility, pain, physical activity habits, the impact of pain on school attendance, and other chronic diseases will be collected through a questionnaire.
The questionnaire consists of 14 questions, of which 11 are multiple-choice questions, two with numerical rating scale answer options and one pain drawing.
Measured: Baseline, pre-intervention
Demographics caregiver
Back ground data of the caregiver concerning education, type of employment and marital status, family history of pain, the caregiver's experience of the child's pain and physical activity level will be collected through a questionnaire.
The questionnaire consists of 16 questions, of which 15 are multiple-choice questions, and one pain drawing.
Measured: Baseline, pre-intervention
Functional Disability Inventory
Functional Disability Inventory (FDI) is a self-report inventory consisting of 15 items that are graded on a five-point scale, ranging from 0 to 4 ("No Trouble" to "Impossible"). The FDI assessed difficulties with the performance of daily activities in home, school, recreational, and social domains. Participants are asked to rate how much difficulty they had completing various tasks, "in the past few days". The sum of answers creates a total score (range 0-60) with higher scores indicating greater pain-related disability. The FDI was created for use in children and adolescents 8-17 years old with recurrent abdominal pain.
Measured: Immediately after the intervention
Frequency of Participation Questionnaire
Participation will be measured using the Frequency of Participation Questionnaire (FPQ). The question is developed to measure the child's participation in all areas of the International Classification of Functioning, Disability and Health.
FPQ consists of 14 questions about participation in everyday activities such as school and leisure.
Participants indicate how often an activity is carried out. Grading from 0 ("never") to 5 ("a few times per week").
Measured: Immediately after the intervention
Multidimensional Fatigue Scale
Fatigue will be measured with the Pediatric Quality of Life Inventory (PedsQL) Multidimensional Fatigue Scale.
PedsQL Multidimensional Fatigue Scale is a self-assessment form that consists of 18 statements that are graded on a five-point scale, from 0 "never a problem" to 4 "almost always a problem". The PedsQL scale consists of three subscales: General Fatigue, Sleep/Rest Fatigue, and Cognitive Fatigue. The Child/Adolescents questionnaire includes ages, 5-7, 8-12 and 13-18.
Items are reversed scored and linearly transformed to a 0-100 scale, so that higher scores indicate better outcome. To reverse score, the 0-4 scale items will be transformed to 0-100 as follows: 0=100, 1=75, 2=50, 3=25, 4=0.
Measured: Immediately after the intervention
Pain Catastrophizing scale
Catastrophizing will be measured with the child version of the Pain Catastrophizing scale (PCS-C).
The PCS-C is a self-assessment form that consists of 13 statements that are graded on a five-point scale, from 0 "not at all" to 4 "very much". The total score is 52 points where higher scores indicate higher catastrophizing thoughts. In agreement with previous study using PCS - C to investigate movement loss in children and their parents shared the result on PCS-C in this study into low (0-14 points), between.(15-25 points) and high (26-52) estimated disaster thoughts.
Measured: Immediately after the intervention
Hospital anxiety and depression scale
Anxiety and depression will be measured with the Hospital anxiety and depression scale (HADS).
HADS is a self-assessment form developed to measure anxiety and depression in patients in somatic care. HADS consists of 14 statements with seven statements for each subscale: HADS anxiety and HADS depression that are graded on a four-point scale from 0 to 3 points. The participant should decide how often he or she has known in the last week, for example "as if something terrible will happen" or whether he or she "appreciates the same things as before". The scores from the seven different statements per sub-scale are combined and can amount to a maximum of 21 points per sub-scale. 0-7 points: Does not speak for anxiety/depression, 8-10 points: The score may be an indication of an anxiety or depression condition in the person, 11 points or more: Demonstrate a likely depression or anxiety of clinical significance.
Measured: Immediately after the intervention
Physical activity
Physical activity was measured with Axivity AX3 triaxial accelerometer (Axivity Ltd, UK).
The participants were instructed to wear it attached to the right thigh with medical tape for seven days.
Measured: Continuous measurement over seven days, immediately after the intervention
Diary
Participants will record planned physical activity and the time when they go to bed and get up parallel to the activity measurement.
Measured: Continuous measurement over seven days, immediately after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Dec 2022
- Study start25 Nov 2022
- Primary completion30 Jun 2023
- Study completion31 Oct 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Joint Hypermobility SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Vastra Gotaland Region
- Sponsor type
- Other government
- Collaborators
- Göteborg University
- Responsible party
- Principal investigator, Elke Schubert Hjalmarsson, Vastra Gotaland Region
- Investigators
- Mari Lundberg, Professor, Study director, University of Gothenborg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05633225
- Sponsor's protocol ID
- CSaPhA-HSD/hEDS
- Status last verified
- Nov 2023
- First submitted
- 19 Oct 2022
- Last updated
- 7 Nov 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is not a plan to make IPD available.
Publications
Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):148-157. doi: 10.1002/ajmg.c.31539. Epub 2017 Feb 1.
PubMed 28145606Schubert-Hjalmarsson E, Fridolfsson J, Arvidsson D, Borjesson M, Lundberg M. Exploring physical activity patterns in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos Syndrome. Pediatr Rheumatol Online J. 2025 Jul 8;23(1):69. doi: 10.1186/s12969-025-01124-0.
PubMed 40629345
Study at a glance
From the registry record, last updated by the sponsor on 7 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Measuring Central Sensitization and Physical Activity in Adolescents With Hypermobility Spectrum Disorder or Hypermobile Ehlers-Danlos Syndrome
- ClinicalTrials.gov ID
- NCT05633225
- Acronym / sponsor ID
- CSaPhA-HSD/hEDS
- Keywords
- Pain, Hypermobility, Physical activity, Central sensitization, Fatigue, Ehlers Danlos Syndrome
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Vastra Gotaland RegionOther government
- Collaborators
- Göteborg University
- Study start
- 25 Nov 2022 (actual)
- Primary completion
- 30 Jun 2023 (actual)
- Study completion
- 31 Oct 2023 (actual)
- First posted
- 1 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hypermobility Spectrum Disorder and hypermobile Ehlers-Danlos Syndrome (HSD/hEDS) is under-recognized and poorly understood and its management is therefore not clear.
The goal of this study is to better understand pain and its impact on function in the daily activities of adolescents with Hypermobility Spectrum Disorder and/or hypermobile Ehlers-Danlos Syndrome.
This study will explore the presence of the pain sensitivity status after physical exercise as well as movement behaviour in adolescents with HSD/hEDS compared to a healthy control group.
Detailed description
All participants will be asked not to undertake physical exercise at least 48 hours before the measurements, and to refrain from consuming caffeine, alcohol or nicotine. For ethical reasons, the patients are allowed to take non-opioid pain medicine as described in the first step of the World Health Organization analgesic ladder (COX-inhibitors and paracetamol), however the patients will be asked to abstain from these medications during the 24 hours period before the measurements.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patient-group | – | Other: Submax exercise test on a bicycle ergometerNinety adolescents, 13-17 years of age Diagnosed with Hypermobility Spectrum Disorder or hypermobile Ehlers Danlos Syndrome. |
| Control-group | – | Other: Submax exercise test on a bicycle ergometerNinety adolescents, 13-17 years of age. Participants have to be pain free at time of investigation (NRS score <3/10) |
Who may qualify
- Ages
- 13 to 17 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- Adolecents diagnosed with HSD/hEDS, at Children's Primary Health Care Clinics in Gothenburg and Southern Bohuslän, and at Queen Silvia Children's Hospital and Skaraborgs hospital Skövde will be asked to participate. In addition, a control group of healthy pain free adolecents, matched for sex, age will be recruited from different schools in the region, throw hospital stuff and social media.
Key inclusion criteria (5 listed)
- Able to read and understand Swedish
- Diagnosed with HSD or hEDS
- Able to read and understand Swedish
- Healthy
- Pain free at time of investigation (Numerical Rating Scale score <3/10).
Key exclusion criteria (6 listed)
- Pregnancy and one year postpartum.
- Other syndromes with hypermobility such as the Marfan syndrome, Osteogenesis Imperfecta or other types of EDS.
- Co-morbidity with neurological disorders
- Pregnancy and one year postpartum.
- Past or present signs of rheumatic, neurologic, musculoskeletal, metabolic diseases.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Submax exercise test on a bicycle ergometerTo achieve exertion and not exhaustion, cycling will be stopped at 75% of the expected maximum heart rate (maximum heart rate of 220 beats per minute minus age) as a target value. If the participant then indicated that they do not feel strained, the cycling will continue until the participant experienced an effort on Borg Rating of Perceived Exertion Scale scale of 15 (hard). | Other | Control-group, Patient-group |
Primary outcome
Pressure Pain thresholds, primary and secondary hyperalgesia
Time frame: Baseline, pre-intervention
A hand-held pressure algometer (Wagner Instruments, FPX 25) will be used to assess pressure pain thresholds (PPT). The 1 cm2 rubber tip of the algometer will be positioned at an angle of 90 degrees in relation to the body part evaluated and pressure will be applied at a rate of 1 kg/s. PPT measurements will be carried out on the lower back in the supine position, on the tibialis anterior in the prone position, on the trapezius and deltoid while sitting. The participants will be instructed to say "stop" as soon as the sensation of a pressure changes to an uncomfortable feeling. The pressure algometer will be removed immediately and the recorded value will be noted. This procedure will be repeated time three times at each test location (30 seconds between each measurement). Average value of the last two measurements is used as the baseline. The order of the PPT measurement points will be randomized for each group.
Change of Pressure Pain thresholds, exercise-induced hyperalgesia
Time frame: Immediately after the intervention
Exercise-induced hyperalgesia will be measured by repeating the pressure pain thresholds (PPT) measures at the trapezius muscle and the tibialis anterior muscle (as described above) immediately after the performance of an submax exercise test on a bicycle ergometer The order of the PPT measurement points in the exercise-induced hyperalgesia measurements will be randomized for each group.
14 secondary outcomes
Numerical rating scale
Time frame: Baseline, pre-intervention and immediately after the intervention
Heart rate
Time frame: Immediately after the intervention
Borg Rating of Perceived Exertion Scale
Time frame: Immediately after the intervention
Medical examination
Time frame: Baseline, pre-intervention
Beighton scale
Time frame: Baseline, pre-intervention
Demographics child
Time frame: Baseline, pre-intervention
Demographics caregiver
Time frame: Baseline, pre-intervention
Functional Disability Inventory
Time frame: Immediately after the intervention
Frequency of Participation Questionnaire
Time frame: Immediately after the intervention
Multidimensional Fatigue Scale
Time frame: Immediately after the intervention
Pain Catastrophizing scale
Time frame: Immediately after the intervention
Hospital anxiety and depression scale
Time frame: Immediately after the intervention
Physical activity
Time frame: Continuous measurement over seven days, immediately after the intervention
Diary
Time frame: Continuous measurement over seven days, immediately after the intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Nov 2023.
- Background: PubMed 28145606Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):148-157. doi: 10.1002/ajmg.c.31539. Epub 2017 Feb 1.
- Derived from this study: PubMed 40629345Schubert-Hjalmarsson E, Fridolfsson J, Arvidsson D, Borjesson M, Lundberg M. Exploring physical activity patterns in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos Syndrome. Pediatr Rheumatol Online J. 2025 Jul 8;23(1):69. doi: 10.1186/s12969-025-01124-0.
- hEDS Diagnostic ChecklistLink provided by the sponsor.
- Individual participant dataSharing planned: No. There is not a plan to make IPD available.
Related trials for Joint Hypermobility Syndrome
Enrolling by invitationObservational study
Presentation of Young Adults With and Without Joint Hypermobility
Hypermobile Ehlers-Danlos Syndrome, Postural Orthostatic Tachycardia Syndrome (POTS)
Not yet recruitingPhase 1/2
Regenerative Medicine for Joint Hypermobility and Instability
Ehlers-Danlos Syndrome Hypermobility Type (hEDS), Ehlers-Danlos Syndrome (EDS)
Active, not recruiting
Exercise in Patients With Hypermobile Joints and Knee Pain
Hypermobility, Joint, Hypermobility Syndrome
Not yet recruiting
Hamstring Strengthening in Hypermobile Conditions
Hypermobile EDS (hEDS), Hypermobile Ehlers-Danlos Syndrome
Enrolling by invitation
Functional and Performance Determinants in Climbers: Examining the Role of Mobility, Stability, and Fatigue Across Proficiency Levels
Fatigue, Joint Hypermobility Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mari Lundberg, Professor study director
University of Gothenborg
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Joint Hypermobility Syndrome and Hypermobile Ehlers-Danlos Syndrome, run by Vastra Gotaland Region at 2 sites in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pressure Pain thresholds, primary and secondary hyperalgesia (time frame: Baseline, pre-intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05633225, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2023.